Background
==========

Tuberculosis (TB) incidence in Germany is low -- 5.3 cases per 100,000 inhabitants in 2011 \[[@R1]\]. In spite of the low incidence among the general public, healthcare workers (HCW) continue to have an increased risk of TB \[[@R2]\], \[[@R3]\], \[[@R4]\]. In Germany between 60 and 80 cases of TB in HCW are recognized as an occupational disease each year \[[@R5]\].

In countries with a low TB incidence, the relative risk of TB among HCWs might not exceed the risk for the general population because HCW do not share other TB risk factors such as homelessness or drug addiction and not all HCWs have an increased risk of exposure to *Mycobacterium tuberculosis* \[[@R6]\]. However, the risk of exposure to TB is higher for a wide range of tasks or facilities in healthcare, such as laboratory work, pneumology departments, infection wards, emergency rooms, pathology and geriatric care \[[@R7]\], \[[@R8]\], \[[@R9]\]. For this reason, TB in HCWs is on the list of occupational diseases compiled by the International Labour Organization (ILO) \[[@R10]\]. Different infection control measures have been proposed \[[@R11]\], repeated screening of exposed HCW being one of these infection control measures. Occupational health examinations for HCW raise HCWs' awareness of possible latent TB infection (LTBI) and suitable preventive treatment. They also serve to reduce the risk of nosocomial infection by an infectious colleague for HCW and patients.

TB screening of HCWs has been performed using the interferon-gamma release assay (IGRA) for several years \[[@R9]\], \[[@R12]\]. However, IGRA variability gives rise to concerns about the usefulness of IGRA in serial testing of HCW \[[@R12]\], \[[@R13]\], \[[@R14]\], \[[@R15]\], \[[@R16]\]. The introduction of a borderline zone for the interpretation of the IGRA might be an option to circumvent the variability problem of IGRA in the serial testing of HCW \[[@R13]\], \[[@R17]\], \[[@R18]\], \[[@R19]\], \[[@R20]\]. Instead of a simple negative-positive interpretation "true" conversions or reversions of the IGRA would be defined as trespassing of the borderline zone. Two IGRA are commercially available, the ELISA-based QuantiFERON^®^-TB Gold In-Tube (QFT) and the ELISPOT-based T-SPOT.TB^®^. For the interpretation of the T-SPOT.TB a borderline zone of 5--7 spots has been proposed by CDC and ECDC \[[@R21]\], \[[@R22]\]. However, this recommendation is based on little data \[[@R13]\]. For the QFT different borderline zones were proposed recently \[[@R17]\]. However, one paper cautioned against the use of a borderline zone in HCW with known unprotected exposure to *M. tuberculosis* \[[@R15]\]. For QFT interpretation in serial TB screenings of German HCW a borderline zone of ≥0.2 to ≤0.7 IU/mL is proposed \[[@R23]\]. Using this borderline zone reduced the number of conversions and reversions considerably without inflating the number of QFT results that fall into the borderline zone and can thus only be interpreted with uncertainty.

In order to gain further insights into the usefulness of a borderline zone for QFT interpretation in serial testing of HCW a prospective follow-up study was conducted in the course of which healthcare trainees were TB-screened three times during their three years of training.

Material and methods
====================

Study population
----------------

In the prospective cohort study all trainees who began their training as a healthcare worker or a nurse at the Vivantes Institute for Occupational Education in Health Care in Berlin on 1 October 2008 or 1 April 2009 were QFT-tested on three different occasions. The first test was performed at the start of the training before the first practical deployment. The second was carried out at the midterm of the three-year training period. The third test took place at the end of the training. The results of the first and the second test have been published previously \[[@R24]\]. During the training, the trainees were deployed in different wards of the hospital group.

Data was collected by the supervising doctor and nurse responsible for occupational medicine and was passed on in anonymous form. The repeated tests were arranged independently by the doctor and nurse responsible for occupational medicine, ensuring that the forms filled in at the three examinations could be linked by an anonymous code. The occupational health physician ensured that care of affected persons (those with a positive QFT) was in accordance with the recommendations of the German Central Committee against Tuberculosis (DZK) on contact tracing and consisted of two X-rays to rule out active TB within a year and, if necessary, the prescription of chemoprevention with Isoniazid for at least six months \[[@R25]\].

Ethics
------

Participation in the study was voluntary. To ensure anonymity, no names or other identifiers were used. All participants gave their written and informed consent for participation in the study, which had been approved by the Hamburg Medical Council's Ethics Commission.

Diagnostics
-----------

The initial occupational health check was conducted when the trainees started training. This included a physical examination to assess suitability for a career in healthcare and a general series of routine laboratory tests. In addition, for study purposes a QFT was performed. The QFT was carried out in accordance with the manufacturer's instructions. BCG vaccination status was verified either by an entry in the trainee's vaccination certificate or by means of anamnesis and vaccination scars.

Questionnaire
-------------

Standardised questionnaires were used to collect socio-demographic data on age, gender, country of birth and nationality. The first questionnaire also covered details of private infection risk, personal history of TB (exposure), BCG vaccination and previous employment in the social sector. The main focus of questions in the second and third questionnaires was on assessing a possible occupational infection risk. Variables included previous areas of practical work and contact with TB patients as well as the nature and duration of (protected and unprotected) contact with these patients.

Analysis and statistical evaluation
-----------------------------------

Descriptive data evaluation was undertaken using SPSS, Version 18 (SPSS Inc., Chicago, Illinois). The Friedman test was used to check whether the median differed for the three successive interferon-γ (IFN) concentrations measured.

Results
=======

Description of the study population (baseline)
----------------------------------------------

At baseline the study comprised 194 trainees. The three-year follow-up was completed by 142 (73%) participants (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}). All participants reported immune competence. 70% of the trainees were women. The average age was 23 with a standard deviation of 5.5 years. The youngest study participant was 17 and the oldest 53. The majority of trainees (92.8%) were born in Germany, with 14 subjects (7.2%) born abroad (Table 1). The latter all came from countries with an intermediate or a high incidence of TB (annual incidence of TB \>20 per 100,000 population). Two were from Africa (Ethiopia and Cameroon), two from Asia (Nepal and Pakistan), one from Chile and nine from Eastern Europe (Poland, Romania, Turkey, Russia and Kosovo, no table).

One hundred and seven trainees (55.2%) had undergone BCG vaccination. Most of the trainees (96.4%) had gained previous healthcare experience by means of internships, a voluntary social year, civilian (as an alternative to military) service, work for a rescue service or as helpers in nursing homes. Only seven test subjects stated that they had no previous experience of social work prior to the beginning of training. Anamnesis revealed that one study participant who completed the follow-up had been diagnosed with active TB and had been treated correspondingly in 2002 (Table 1 [(Tab. 1)](#T1){ref-type="fig"}).

During the first year of training 40 trainees (20.6%) dropped out, so the study population for the first follow-up was 154 trainees. A further 12 trainees dropped out of the training after midterm, leaving 142 subjects (73.2%) for testing at the end of the training course (Figure 1). All eligible trainees agreed to be QFT-tested (response rate 100%).

In total, 490 QFT were performed and 8 (2%) were positive. Fourty participants had one QFT, 154 had two QFT and 142 had three consecutive QFT. One student out of 142 (0.6%) was positive in all three QFT. This student had been treated for TB in 2002 and originated from Ethiopia (Table 2 [(Tab. 2)](#T2){ref-type="fig"}). One reversion, one conversion and one fluctuating QFT (neg, pos, neg) were observed. One indeterminate QFT was observed in the first test series (0.5%). The second and third QFT were negative. In the second and third test series no indeterminate QFT was observed.

In those six students in whom the QFT was positive at least once, active TB was ruled out by chest X-ray. One participant reported having spent a longer period abroad in a high-incidence country after the first QFT and remained negative in the two following QFT. Three more students spent time abroad after the second QFT and remained negative in the third QFT. Contact with TB patients was reported by 42 trainees (29.6%) during the whole follow-up. In 24 cases these were contacts with both culturally and microscopically confirmed index cases and in three with microscopically negative but culturally confirmed TB index cases. The other 15 participants did not specify the contacts. The trainees with the conversion or the fluctuating QFT had no known TB contact. Trainees were deployed to different healthcare units, from internal medicine, surgery, psychiatry, gynaecology and maternity wards to outpatient work at the welfare centre.

Two participants with a positive QFT at baseline with IFN concentrations of 12.0 IU/mL and 0.67 UI/mL quit training within the first year. The IFN concentrations of the inconsistent positive QFT were between 0.47 and 1.75 IU/mL. If a borderline zone from 0.2 to 0.7 IU/mL was used, the conversion (0.02 to 0.47 IU/mL) and the fluctuating QFT (0.01 to 0.68 to 0.00 IU/mL) pertained to this borderline zone. The number of unexplained positive QFT therefore decreased from three (2.1%) to one (0.7%) by applying this borderline zone for trainees with no known TB contact.

One hundred and thirty-nine participants tested consistently QFT-negative with IFN concentrations of between zero and 0.31 IU/ml. The median of the IFN concentration was changed from 0.00 IU/mL in the initial QFT to 0.01 IU/mL in the second QFT and remained unchanged in the third QFT (Figure 2 [(Fig. 2)](#F2){ref-type="fig"}). No statistically significant difference was observed when comparing the median concentrations of the three consecutive QFT.

No case of active tuberculosis was diagnosed during follow-up over a three-year observational period.

Discussion
==========

This is the first study to investigate the performance of the QFT in serial testing of nursing trainees with a low risk of unprotected exposure to *M. tuberculosis* over a period of three years with three consecutive QFT. The probability of a positive QFT in this young cohort with limited TB exposure was low. The only person with a continuously positive QFT had a history of active TB. Three further participants showed at least one positive QFT. However, when applying a borderline zone from 0.2 to 0.7 IU/mL, two out of these three participants had a QFT within this zone. As no active TB was diagnosed at baseline and during follow-up and as the few trainees with a QFT conversion had no known TB contact, the use of the proposed borderline zone in this group with a low TB risk seems to be safe.

IGRA are dynamic assays and IFN values tend to fluctuate around the cut-off, leading to apparent conversions and reversions \[[@R26]\]. Reasons for the test variability of IGRA may be based on variations of handling and reading of the test, variability of the immune system and differences in the activity of the *M. tuberculosis* infection, that is, transient infection, infection with low replication of *M. tuberculosis* with no stimulation of the immune system or high replication of *M. tuberculosis* with stimulation of the immune system, and uncontrolled replication causing active TB infection \[[@R26]\]. In addition, reversions may be partly explained by the statistical mechanism of regression toward the mean \[[@R13]\], which is a ubiquitous and inevitable statistical phenomenon that occurs whenever repeated measurements on the same subject are observed with random error, i.e., nonsystematic variation around a true mean \[[@R27]\]. In our study the two reversions are most likely explained by regression toward the mean as no TB risk was known for the respective trainees and the QFT concentration of one positive test was below 0.7 IU/mL. The two conversions we observed are most likely due to unspecific variations as well, because again the respective trainees had no known exposure and the positive QFT results were \<0.7 IU/mL. As no active TB was diagnosed in the course of the study, the application of a borderline zone stretching from 0.2 to 0.7 IU/mL for the QFT in this group of HCW with a low TB risk helps to avoid unnecessary chest X-rays and preventive treatment.

In the study by Fong et al. 71% of reversions had IFN values ≤1 IU/mL \[[@R18]\]. The authors therefor argue to extend a putative borderline zone to 0.1 to 1.0 IU/mL. Joshi and colleagues suggested to extend the borderline to 2.0 IU/mL as all reverts in their study had concentrations between 0.35 and 2.0 IU/mL in the baseline QFT \[[@R19]\]. In an attempt to balance sensitivity and specificity of the QFT and to minimize conversions that might lead to unnecessary preventive treatment, a threshold of 1.11 IU/mL was proposed for serial QFT testing of HCW in the US \[[@R17]\]. Following these recommendations, low risk individuals with an initial QFT ≥0.35 IU/mL and ≤0.7, 1.0, 1.11 or 2.0 IU/mL should be retested by clinicians. As in none of these studies active TB at baseline or progression from LTBI to active TB was observed, it is impossible to tell which of the upper limits of a borderline zone should be applied. Our study does not help either to decide which borderline zone is most appropriate as using either of these borderline zones with an upper limit of 0.7, 1.0, 1.1 or 2.0 IU/mL would only affect the interpretation of one positive QFT (1.75 IU/mL, Table 2). As there is no biological but only a statistical reason for introducing a borderline zone for serial testing of HCW, intuitively, the smaller the borderline zone the greater the confidence in the QFT results. Therefore, the tighter borderline zone seems to be appropriate for our study group. However, it should be borne in mind that even this tight borderline zone of 0.2--0.7 IU/mL increases the risk of false negative QFT results in HCW with prevalent active TB or the risk of progression from LTBI to active TB, as it was shown in the only HCW study that reported diagnosis of active TB when performing routine serial testing of HCW \[[@R15]\].

Risk of LTBI infection
----------------------

LTBI prevalence at the start of training was low (n=4/194, 2.1%). In another German study, no trainees tested positive \[[@R28]\]. There are few comparable studies of TB screening among those beginning careers in the healthcare sector in other countries. Chee and colleagues tested 270 medical students from Singapore in their final semester using the T-SPOT.TB. Here, 4.3% of the students tested positive \[[@R29]\]. Singapore is a country with an intermediate TB incidence. This might account for the prevalence rate of positive IGRA being twice as high as in our study. In a US study, students at the University of Tennessee Health Science Center in Memphis were tested. Retrospectively, all students who had been routinely QFT-tested between June 2005 and August 2006 were included in the study. QFT was positive in 14.8% (8/54) of the students \[[@R30]\]. As only students with positive indicators for a risk of LTBI in their personal history were screened, the high LTBI prevalence rate is not surprising. Hence, the study does not allow for an estimate of the prevalence of LTBI in students in general.

In our study 29.6% of the trainees stated that they had been in contact with TB patients during their practical work but the two participants with the conversions had had no known contact with TB patients. As hygiene standards in Germany are high, contact with TB patients does not necessarily result in exposure to *M. tuberculosis*. Therefore, it seems plausible that none of the trainees who reported contact with TB patients was positive in the QFT.

The sample of our study is rather small and the follow-up period is limited. Thus, conclusions from our study results should be drawn with caution. Cum grano salis, our data does not support the need for regular TB screenings in healthcare trainees in a country with a low TB incidence in the general population and high in-hospital hygiene standards. We assume that our study population was TB unexposed during the study period. Therefore, our recommendations regarding the use of a borderline zone in the serial testing of HCW should only be applied to unexposed groups with a low a priori risk of LTBI.

Conclusions
===========

We observed a low variability of IGRA results in this young and healthy group of trainees with a low risk of TB exposure in the healthcare sector. In countries with a low TB incidence and high hygiene standards, the infection risk during training in healthcare seems to be low and the application of a borderline zone of 0.2--0.7 IU/mL may help to avoid unnecessary chest X-rays and preventive chemotherapy.
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